Stock-based Compensation - Narrative (Details) - USD ($)		1 Months Ended		3 Months Ended			9 Months Ended
	Jun. 09, 2021	May 31, 2023	Jul. 31, 2020	Nov. 30, 2024	Nov. 30, 2023	Aug. 31, 2023	Nov. 30, 2024	Nov. 30, 2023	Feb. 29, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation expense				$ 10,053,000	$ 15,644,000		$ 37,038,000	$ 45,648,000
Restricted stock units 2023 Bonus plan payout
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Units issued (in shares)		747,687
Unvested performance stock units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							3 years
Compensation expense				101,000	138,000		$ 570,000	211,000
Unrecognized compensation expense				$ 3,414,000			$ 3,414,000
Weighted average period							2 years
Unvested shares outstanding (in shares)				693,980			693,980		276,480
Unvested performance stock units \| Minimum \| Year One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant based on the actual achievement of performance metrics									0.00%
Unvested performance stock units \| Minimum \| Year Two
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant based on the actual achievement of performance metrics									0.00%
Unvested performance stock units \| Maximum \| Year One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant based on the actual achievement of performance metrics									150.00%
Unvested performance stock units \| Maximum \| Year Two
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Grant based on the actual achievement of performance metrics									200.00%
Individuals Agreements With Company \| PlushCare
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation expense				$ 0	3,519,000		$ 3,905,000	10,663,000
Individuals of company with continued employment (in shares)	806,161
Unvested shares outstanding (in shares)				0			0
Individuals Agreements With Company \| Tranche One \| PlushCare
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period	1 year
Vesting percentage	33.33%
Individuals Agreements With Company \| Tranche Two \| PlushCare
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period	2 years
Vesting percentage	33.33%
Individuals Agreements With Company \| Tranche Three \| PlushCare
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period	3 years
Vesting percentage	33.34%
Unvested restricted stock units
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation expense				$ 8,931,000	9,798,000		$ 28,491,000	25,791,000
Weighted average grant date fair value (USD per share)							$ 6.49
Weighted average period							1 year 9 months 18 days
Remaining of total unrecognized compensation costs				$ 41,503,000			$ 41,503,000
Unvested shares outstanding (in shares)				5,248,889			5,248,889		5,031,140
Unvested restricted stock units \| PlushCare
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares issued in connection with the acquisition to the existing shareholders (in shares)	64,694
Granted (in shares)						57,124
Unvested restricted stock units \| Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							2 years
Unvested restricted stock units \| Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							4 years
Unvested restricted stock units \| Two-Year Vesting Grants
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							2 years
Unvested restricted stock units \| Two-Year Vesting Grants, Tranche One, Quarterly Vesting
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							1 year
Vesting percentage							12.50%
Unvested restricted stock units \| Two-Year Vesting Grants, Tranche Two, Monthly Vesting
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							1 year
Vesting percentage							87.50%
Unvested restricted stock units \| Three-Year Vesting Grants
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							3 years
Unvested restricted stock units \| Three-Year Vesting Grants, Tranche One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting percentage							33.33%
Unvested restricted stock units \| Three-Year Vesting Grants, Tranche One \| Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							1 year
Unvested restricted stock units \| Three-Year Vesting Grants, Tranche Two, Monthly Vesting
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							2 years
Vesting percentage							66.67%
Unvested restricted stock units \| Four-Year Vesting Grants
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							4 years
Unvested restricted stock units \| Four-Year Vesting Grants, Tranche One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting percentage							25.00%
Unvested restricted stock units \| Four-Year Vesting Grants, Tranche One \| Minimum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							1 year
Unvested restricted stock units \| Four-Year Vesting Grants, Tranche Two, Monthly Vesting
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting percentage							75.00%
Unvested restricted stock units \| Four-Year Vesting Grants, Tranche Two, Monthly Vesting \| Maximum
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period							3 years
2020 Equity Incentive Plan
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock authorized to be issued (in shares)				15,257,574			15,257,574
Common stock available for future grants (in shares)				1,589,025			1,589,025
2020 Equity Incentive Plan \| Stock options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock authorized to be issued (in shares)			4,300,000
Term of option (in years)			10 years
Vesting period			4 years
Compensation expense				$ 770,000	1,661,000		$ 3,075,000	5,641,000
Aggregate intrinsic value of stock options				0	653,000		46,000	4,151,000
Unrecognized compensation expense				1,542,000			$ 1,542,000
Weighted average period							8 months 12 days
2020 Equity Incentive Plan \| Stock options \| Tranche One
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period			1 year
Vesting percentage			25.00%
2020 Equity Incentive Plan \| Stock options \| Tranche Two
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vesting period			3 years
Vesting percentage			75.00%
PlushCare, Inc. Stock Incentive Plan \| Stock options
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Compensation expense				56,000	155,000		$ 211,000	2,215,000
Aggregate intrinsic value of stock options				1,000	$ 101,000		170,000	$ 650,000
Unrecognized compensation expense				$ 0			$ 0

Accolade, Inc. 10-Q